Status:
UNKNOWN
Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
Lead Sponsor:
Sheba Medical Center
Conditions:
Retinopathy of Prematurity
Eligibility:
All Genders
2-3 years
Brief Summary
To evaluate the possibility that erythropoietin with early iron supplementation may induce retinopathy of prematurity or worsen this disease. In addition risk factors for the development of ROP will b...
Eligibility Criteria
Inclusion
- all premature infants with birth weight of 1250 grams or less
Exclusion
- none
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
End Date :
December 1 2006
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00339001
Start Date
April 1 2006
End Date
December 1 2006
Last Update
June 20 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neonatal Department, Sheba Medical Center
Ramat Gan, Israel, 52621